Functional Heartburn and Non-Erosive Reflux Disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Digestive Diseases

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000103879PMID 17827934
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring

  2006cited by this paper
• Dilated Intercellular Spaces of Esophageal Epithelium in Nonerosive Reflux Disease Patients with Physiological Esophageal Acid Exposure

  2005cited by this paper
• Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group

  2005cited by this paper
• Short-Term Treatment with Proton-Pump Inhibitors as a Test for Gastroesophageal Reflux Disease

  2004cited by this paper
• Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics.

  2004cited by this paper
• Distinct Phenotypic Presentations of Gastroesophageal Reflux Disease: A New View of the Natural History

  2004cited by this paper
• Functional heartburn: the stimulus, the pain, and the brain

  2002cited by this paper
• Sustained esophageal contraction: a motor correlate of heartburn symptom.

  2001cited by this paper
• Nonerosive Reflux Disease— Current Concepts And Dilemmas

  2001cited by this paper
• Functional esophageal disorders.

  1999cited by this paper
• Functional esophageal disorders

  1999cited by this paper
• Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans.

  1998cited by this paper
• Intraduodenal fat alters perceptual and autonomic responses to acid perfusion of the esophagus in GERD patients

  1998cited by this paper
• Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".

  1997cited by this paper
• Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

  1997cited by this paper
• Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux

  1995cited by this paper
• The effect of low external pH on properties of the paracellular pathway and junctional structure in isolated frog skin.

  1982cited by this paper

• Probiotics versus Rifaximin as Adjuvant Therapy for Helicobacter pylori Eradication

  2025cites this paper
• Pathophysiology of GERD.

  2025cites this paper
• Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED)

  2025cites this paper
• Clinical diagnostic value of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for distinguishing functional heartburn from non-erosive reflux disease

  2024cites this paper
• The Complexity of Mucosal Damage in Gastroesophageal Airway Reflux Disease: A Molecular Perspective

  2024cites this paper
• The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions

  2024cites this paper
• Efficacy and safety of dexlansoprazole: a comprehensive review

  2023cites this paper
• Modern aspects of managing patients with non-erosive reflux disease

  2023cites this paper
• Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis.

  2022cites this paper
• Measurement of low-grade inflammation of the esophageal mucosa with electrical conductivity shows promise in assessing PPI responsiveness in patients with GERD.

  2021cites this paper
• Refractory Gastroesophageal Reflux Disease: A Management Update

  2021cites this paper
• Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases

  2021cites this paper
• Review article - esophageal reflux hypersensitivity: Non-GERD or still GERD?

  2020cites this paper
• Diagnosis of GERD in typical and atypical manifestations

  2018influential citation
• Appropriateness in prescribing PPIs: A position paper of the Italian Society of Gastroenterology (SIGE) - Study section "Digestive Diseases in Primary Care".

  2018cites this paper
• The appropriate use of proton-pump inhibitors.

  2018cites this paper
• Current and future perspectives in the management of gastroesophageal reflux disease

  2018cites this paper
• Gastro Esophageal Reflux Disease: An Imperfect Diagnosis

  2018cites this paper
• Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018

  2018cites this paper
• Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders

  2018cites this paper
• The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.

  2017cites this paper
• A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD)

  2017cites this paper
• Influence of the patient-practitioner interaction context on acupuncture outcomes in functional dyspepsia: study protocol for a multicenter randomized controlled trial

  2017cites this paper
• Epidemiology and natural history of gastroesophageal reflux disease.

  2017cites this paper
• Complexity and diversity of gastroesophageal reflux disease phenotypes.

  2017cites this paper
• Ilaprazole for the treatment of gastro-esophageal reflux

  2016cites this paper
• Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement.

  2016cites this paper
• The natural history of gastro-esophageal reflux disease: a comprehensive review.

  2016cites this paper
• Between GERD and NERD: the relevance of weakly acidic reflux

  2016cites this paper
• Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations

  2016cites this paper
• [Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease].

  2015cites this paper
• Dexlansoprazole – a new-generation proton pump inhibitor

  2015cites this paper
• The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders

  2014cites this paper
• Esophageal motility abnormalities in gastroesophageal reflux disease.

  2014cites this paper
• Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach

  2014cites this paper
• EAES recommendations for the management of gastroesophageal reflux disease

  2014cites this paper
• Effect of acid swallowing on esophageal contraction in patients with heartburn related to hypersensitivity

  2013cites this paper
• The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing

  2013cites this paper
• Functional testing: pharyngeal pH monitoring and high‐resolution manometry

  2013cites this paper
• Distinction between patients with non-erosive reflux disease and functional heartburn

  2013cites this paper
• Moderne Funktionsdiagnostik bei Ösophaguserkrankungen

  2013cites this paper
• NERD: an umbrella term including heterogeneous subpopulations

  2013cites this paper
• Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.

  2013cites this paper
• GERD assessment including pH metry predicts a high response rate to PPI standard therapy

  2013cites this paper
• The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment

  2013cites this paper
• Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus

  2013cites this paper
• Alginate controls heartburn in patients with erosive and nonerosive reflux disease.

  2012cites this paper
• It is time to plan clinical trials on true NERD patients

  2012cites this paper
• Gastroesophageal reflux disease—from reflux episodes to mucosal inflammation

  2012cites this paper
• Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro‐oesophageal reflux disease

  2011cites this paper
• Overweight is a risk factor for both erosive and non-erosive reflux disease.

  2011cites this paper
• The Association Between Cholecystectomy and Gastroesophageal Reflux Symptoms: A Prospective Controlled Study

  2010cites this paper
• Czy jest nam potrzebny esomeprazol ? Do we need esomeprazole ?

  2010cites this paper
• Czy jest nam potrzebny esomeprazol

  2010cites this paper
• Bronchopulmonale Manifestationen der gastroösophagealen Refluxerkrankung

  2010cites this paper
• Proton Pump Inhibitors – Their Pharmacological Impact on the Clinical Management of Acid-Related Disorders

  2009influential citation
• Longitud esofágica: estudio prospectivo en pacientes adultos con enfermedad por reflujo gastroesofágico

  2009cites this paper
• NERD: a new approach in managing reflux

  2008cites this paper
• Proton pump inhibitors: an update of their clinical use and pharmacokinetics

  2008cites this paper
• NERD: a new approach in managing reflux symptoms.

  2008cites this paper
• A Model for Acid Exposure using Trachea Excised from a Guinea Pig

  2008cites this paper
• Is acid relevant in the genesis of dyspeptic symptoms associated with nonerosive reflux disease?

  2008cites this paper